Cartagena Protocol on Biosafety: A Report on Policy Analysis, Program Design and Implementation - Summer

This workshop report investigates the Cartagena Protocol on Biosafety, an international agreement developed under the Convention on Biological Diversity to regulate the transboundary movement of genetically modified organisms (GMOs) and protect biodiversity and human health. The report examines the scientific foundations of genetic engineering and outlines both the potential benefits and risks associated with biotechnology. While genetic modification can increase agricultural productivity, improve nutrition, and support medical innovation, it also raises concerns regarding ecological impacts, genetic contamination, and long-term environmental uncertainty. The analysis situates the Protocol within the broader global debate on biotechnology governance, noting that although many countries have ratified the agreement, major agricultural producers such as the United States have not.

The report focuses on key implementation mechanisms within the Protocol, including Advance Informed Agreement procedures, risk assessment requirements, and the Biosafety Clearing-House, which facilitates information sharing among countries. These tools aim to improve transparency and ensure that importing countries can assess environmental risks before accepting genetically modified organisms. The analysis also explores obstacles to implementation, including scientific uncertainty, regulatory disparities among nations, and tensions between environmental protection and international trade. The report concludes that the Cartagena Protocol represents an important step toward global biosafety governance, but emphasizes that effective implementation will require improved scientific research, international cooperation, and harmonization of regulatory frameworks to address the rapidly evolving field of biotechnology.

Learn more about the MPA-ESP Workshop in Applied Earth Systems Management.